UNSPSC 51281800: Anthracyclines

This classification denotes antibiotics that bear a tetrahydronaphthacenedione ring structure attached by a glycosidic linkage to the amino sugar daunosamine.

UNSPSC 51281800 Anthracyclines is a Class code that does not align with the state and local procurement activity currently tagged under it. The recent opportunities show state and local governments soliciting naloxone and drug deactivation systems, medical and first aid supplies for fire departments, generic pharmaceuticals and over-the-counter products through cooperative purchasing, and pharmacy benefit program services — none of which are anthracyclines, the chemotherapy drug class the code nominally describes. The mismatch suggests either a taxonomy misapplication in source records or that anthracyclines procurement at state and local level is minimal and overshadowed by broader pharmaceutical and medical supply buying. The scope of work actually being transacted includes emergency response supplies, generic drug distribution through wholesalers, and direct-to-manufacturer pharmacy programs rather than specialty oncology pharmaceuticals.

The issuing bodies span county health departments (Seminole County, Florida), municipal fire departments (City of Tampa), state HHS agencies (Texas Health and Human Services Commission), and multistate cooperative purchasing entities (Minnesota Multistate Cooperative Purchasing Alliance serving state and local facilities in Minnesota and Oregon). Geographic activity appears concentrated in Florida, Texas, and the Upper Midwest through cooperative vehicles, with no clear pattern suggesting anthracycline-specific procurement. Representative recent opportunities include Seminole County's IFB for naloxone and drug deactivation systems (due July 26, 2023), the City of Tampa's invitation to bid for medical and first aid supplies for the Fire Department Rescue Division with an estimated contract amount of $700,000.00 (due March 13, 2026, sheltered for certified Small Local Business Enterprises with a 5 percent bid discount), and the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic multi-source pharmaceuticals and OTC products (due March 26, 2026). The code shows little relevant recent activity and the opportunities posted do not reflect anthracycline procurement.